Explorer notre blog pour des articles, des études sectorielles, des points de vue.

Future Thinking launches pharmaceutical healthcare research

Future Thinking has launched a new pharmaceutical healthcare research division.

Building on a growth of 20% in the past 12 months has enabled the group to diversify its expertise into the pharmaceutical and healthcare sector, with the intention to further expand its blue chip client roster across Europe.

The new division will be known as Future Thinking Pharma and will be headed by Béatrice Chemla, previously founder and CEO of Listening Pharma. It will provide a complete range of products and bespoke qualitative and quantitative research solutions to aid strategic decision making.

Jon Priest, CEO at SPA Future Thinking, comments. “Béatrice brings a wealth of experience within the pharmaceutical and healthcare sector and worked with an impressive client portfolio at her previous agency.”

Stéphane Marder, CEO at Future Thinking’s French office, comments. “The creation of Future Thinking Pharma is an important step in our growth strategy. Strengthening and formalising our healthcare expertise will enable us to offer the pharmaceutical industry unique and innovative tools developed by Quantum Lab, our in-house think tank of new ideas, approaches and products. These tools and analytical techniques have been instrumental in driving our growth in the past two years and have previously been reserved for the FMCG or services sectors.

Partagez cet article:TweetShareEmailPrint